Mylan says EpiPen pretax profits 60% higher than it told Congress: Report
Mylan said on Monday the auto-injector EpiPen pretax profits were higher than it told Congress, according to Dow Jones.
Continue Reading
Mylan said on Monday the auto-injector EpiPen pretax profits were higher than it told Congress, according to Dow Jones.
Continue Reading
Join the Discussion